Skip To Main Content
Sweden. Fischer K on Muck Rack

Sweden. Fischer K

Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Sweden. Fischer

Contact Sweden. Fischer, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

|
By Al-Sawaf O, et al. Venetoclax-obinutuzumab, Sweden. Fischer K
| chase.com
AbbVie Presents New Data at EHA 2026 Congress for VENCLEXTA/VENCLYXTO (venetoclax) in First-Line Chronic Lymphocytic Leukemia Highlighting Long-Term Treatment Outcomes for Patients: Nine-Year Results 3:00 AM EDT 6/12/2026 - Comtex NORTH CHICAGO, Ill., June 12, 2026 /PRNewswire via COMTEX News Network/ -- AbbVie (NYSE: ABBV) today announced new Phase 3 data on a fixed-duration venetoclax-based combination at the European Hematology Association (EHA) 2026 Congress taking place June 11-14 in...
Open in Who Shared View Duplicates (197) Issue with article?
See all 2 articles